Preclinical toxicology study of drugs developed for cancer and other diseases

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201100019C
Awardee
Awarding agency
Obligated
$2,950,541

Award facts

Opportunity
Contract value 29% obligated
  • $4,593,121.26 Current, with exercised options
  • $10,343,380.26 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition after exclusion of sources · 9 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Columbus, OH 43201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00029 · Final_close_process -DE-obligation of funds -$137,527
Funding Only Action 28 -$6,604
Other Administrative Action 27 -$1,950
Other Administrative Action 26 $60,052
Other Administrative Action 25 $0
Other Administrative Action 24 $89,937
Other Administrative Action 23 · LOC modification. Add money from DE-obgliation $175,688
Other Administrative Action 22 -$175,688
Funding Only Action 21 $29,192
Funding Only Action 20 $20,941
Other Administrative Action 19 $0
Supplemental Agreement for work within scope 18 $34,615
Other Administrative Action 17 $238,693
Other Administrative Action 16 $98,406
Supplemental Agreement for work within scope 15 $2,521
Other Administrative Action 14 $0
Funding Only Action 13 $115,366
Other Administrative Action 12 $0
Funding Only Action 11 $179,132
Funding Only Action 10 $116,047
Other Administrative Action 9 $0
Funding Only Action 8 · Incremental funding modification $8,167
Other Administrative Action 7 · Other functions incremental funding modification preclinical toxicology study of drugs developed for cancer and other diseases $475,231
Exercise an Option 6 $570,007
Funding Only Action 5 $150,000
Funding Only Action 4 $140,000
Funding Only Action 3 · Incremental funding modification $65,972
Funding Only Action 2 · Incremental funding modification for preclinical toxicology of drugs for clinical trials $599,050
Funding Only Action 1 · Incremental funding modification $53,293
Original award $50,000
Show all 30

Quick answers

Who was awarded contract HHSN261201100019C?

HHSN261201100019C was awarded to Battelle Memorial Institute by National Cancer Institute (National Institutes of Health) on July 1, 2011.

How much is contract HHSN261201100019C worth?

The government has obligated $2,950,541 on HHSN261201100019C. Its current value, with exercised options, is $4,593,121. Its potential value, with all options, is $10,343,380.

Was contract HHSN261201100019C competed?

The extent of competition for HHSN261201100019C was full and open competition after exclusion of sources. The government received 9 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login